The rapid rise of the number of diagnosis in the 1990s, as well as the combination of a high number of diagnosis and a low number of mortality in 2008, may be mainly attributed to the increased availability of screening tests such as the prostate-specific antigen (PSA), which permit early detection of prostatic cancer in the human [66]. The gene discussed is KLK3; the disease is prostate carcinoma.